Study of new oral antiplatelet therapy (prasugrel, ticagrelor) in comparison with aspirin and clopidogrel to patients with Coronary Artery Disease and Acute Coronary Syndrome

Study of new oral antiplatelet therapy (prasugrel, ticagrelor) in comparison with aspirin and clopidogrel to patients with Coronary Artery Disease and Acute Coronary Syndrome

Learning Goals:
• To discuss the role of antiplatelet therapy in patients with CAD & ACS
• To study and discuss the mechanism of action of prasugrel, ticagrelor, aspirin & clopidogrel in platelet inhibition
• To discuss the adverse effects of each
• To be able to compare the new oral antiplatelets (ticagrelor and prasugrel) to old antiplatelets (aspirin and clopidogrel) and the reason for its shift

Use the order calculator below and get started! Contact our live support team for any assistance or inquiry.

[order_calculator]